Clinical observation of influence of Shenkang injection on serum cystatin C of patients with early diabetic nephropathy
Jun-Bo Yao
Abstract
Jun-Bo Yao
Abstract
Objective To investigate the impact of Shenkang injection on the serum cystatin C (Cys C) of patients with early diabetic nephropathy. Methods Sixty patients with early diabetic nephropathy were randomly divided into the control group and the treatment group. The control group received conventional western medicine treatment and the treatment group received conventional western medicine treatment as well as Shengkang injection. The serum Cys C contents before and after the treatment were detected. Results In the treatment group,the content of serum Cys C significantly reduced after the treatment compared to that before the treatment (P0.05), of which the degree of reduction was superior to that of the control group(P0.05). Conclusion The content of serum Cys C reduces more significantly in the treatment group after the treatment, indicating that the adjuvant application of Shenkang injection shows better efficacy in the treatment of early diabetic nephropathy.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the impact of Shenkang injection on the serum cystatin C (Cys C) of patients with early diabetic nephropathy. Methods Sixty patients with early diabetic nephropathy were randomly divided into the control group and the treatment group. The control group received conventional western medicine treatment and the treatment group received conventional western medicine treatment as well as Shengkang injection. The serum Cys C contents before and after the treatment were detected. Results In the treatment group,the content of serum Cys C significantly reduced after the treatment compared to that before the treatment (P0.05), of which the degree of reduction was superior to that of the control group(P0.05). Conclusion The content of serum Cys C reduces more significantly in the treatment group after the treatment, indicating that the adjuvant application of Shenkang injection shows better efficacy in the treatment of early diabetic nephropathy.
Key concepts: Medicine, Diabetic nephropathy, Cystatin C, Nephropathy, Internal medicine, Urology, Western medicine, Adjuvant